Remove 2019 Remove Hospital Remove Individual Remove Patients
article thumbnail

Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes [Diabetes and endocrine disease]

Annals of Family Medicine

Objectives To assess overall medication adherence as an indicator for emergency room (ER) visits, hospitalizations, and mortality among elderly patients. We determined personal adherence rates by calculating the mean adherence rates of the medications prescribed to each individual. The mean age was 81.2

article thumbnail

ICU Statin Therapy Tied to Significant Sepsis Mortality Reduction

Physician's Weekly

Recent research showed that ICU statin therapy was associated with significantly lower 28-day all-cause mortality for critically ill patients with sepsis. Statin use is associated with significantly lower 28-day all-cause mortality for critically ill patients with sepsis, according to a study published online in Frontiers in Immunology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health and Mood Benefits of Semaglutide in HF

Physician's Weekly

Semaglutide therapy in patients with obese heart failure leads to marked weight loss and notable gains in mood, function, and QoL over the course of 1 year. Source: link.springer.com/article/10.1007/s00392-025-02694-5 The post Health and Mood Benefits of Semaglutide in HF first appeared on Physician's Weekly.

article thumbnail

Minnesota Proposes to Reduce Opioid Product Registration Fees Related to Hospitals

FDA Law

Richardson — A recent proposed amendment to Minnesota’s Opiate Product Registration Fee appears intended to ensure continued availability of certain opiate products at hospitals. Gilbert & Kalie E. If enacted, Article 5, Section 6 of HF33 would provide for a reduction to the State’s opiate product registration fee. 151.066, Subd.

article thumbnail

Episode 282: Anti-Racism in Medicine Series – Episode 20 – Medical Racism and Indigenous Peoples

The Clinical Problem Solvers

Michael’s Hospital in Unity Health Toronto, and Dr. Alika Lafontaine, the current President of the Canadian Medical Association. The dehumanization of individuals of color at the margins of society by the healthcare system is not simply a thing of the past, and is certainly a persistent phenomenon.

Medical 52
article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

A multilayered view of stigmatizing discourses lays the foundation for eliciting a series of suggestions for quelling stigma, to be implemented at the individual, community, and national levels, as suggested by the WHO. Psychological health during the coronavirus disease 2019 pandemic outbreak. Scholars such as Wen et al.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

19:05 Clarifying the “ethics vs science” argument and critiquing research techniques 22:00 Resurgence of race-based speculation in COVID-19-related research 25:57 Implantation of ideas about innate racial inferiority within medicine 28:32 Will removal of race from algorithms potentially harm our patients?

Clinic 52